CSIMarket
 

Damora Therapeutics Inc   (NASDAQ: DMRA)

Damora Therapeutics Inc 's

Competitiveness




 

DMRA Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Damora Therapeutics Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 4.9 %, recorded in the same quarter.

List of DMRA Competitors





Revenue Growth Comparisons




Net Income Comparison


Damora Therapeutics Inc , slower than the average decrease reported by the company's competitors of -74.16 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -74.16 %

<<  DMRA Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Damora Therapeutics Inc




Sanofi
Share Performance



+2.97%
30 Days



Sanofi
Profile

Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.

More about Sanofi's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 108,735.232 mill. $ 52,321.040 mill. $ 8,793.120 mill.


Bicycle Therapeutics Plc
Share Performance



-11.56%
This Quarter



Bicycle Therapeutics Plc
Profile

Bicycle Therapeutics Plc's business model is centered around the development and commercialization of novel therapeutics using its proprietary bicyclic peptide platform.

More about Bicycle Therapeutics Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 287.793 mill. $ 63.496 mill. $ -219.031 mill.


Biovie Inc
Share Performance



+44.30%
One Year



Biovie Inc
Profile

Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients.

More about Biovie Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 17.200 mill. $ - mill. $ -19.916 mill.


Bristol myers Squibb Company
Share Performance



+40.92%
One Year



Bristol myers Squibb Company
Profile

Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.

More about Bristol myers Squibb Company's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 136,760.070 mill. $ 48,482.000 mill. $ 7,271.000 mill.


Casi Pharmaceuticals inc
Share Performance



-0.92%
30 Days



Casi Pharmaceuticals inc
Profile

CASI Pharmaceuticals, Inc. and its subsidiaries operate in pharmaceutical development and manufacturing.

More about Casi Pharmaceuticals inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.388 mill. $ 20.712 mill. $ -48.058 mill.

103 more competitors available

Sign in to see all competitors

Sources: Damora Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Damora Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.